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Problem 
 
Many cats, like dogs, suffer from different diseases. which at the time do not allow 
to show symptoms or signs that allow to identify that the pet is suffering a serious 
and severe disease, since the characteristics of the cats are different from those of 
the dogs, since these are predators, therefore the Diagnosis of diseases in this 
species is difficult, and in most cases the diagnosis is made during the advanced 
stages, thus causing difficult treatment and poor prognosis. These diseases include: 
feline hypertrophic cardiomyopathy, feline hepatic lipidosis, feline immunodeficiency 
virus, chronic renal failure and feline infectious peritonitis. It requires knowledge 
about biomarkers to be able to give the result. Biomarkers are a tool that is not yet 
widely known and this is necessary. Since it allows to improve the quality of life of 
cats and their owners, since cats have become increasingly important as pets. It is 
estimated that a high percentage of the world population has chosen to have cats 
as pets because of their physiological and behavioral characteristics. 
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Justification 
 
 
Cats, other mammals and pets have different disease viral, bacterial, parasitic and 
congenital among others, since the diagnosis of the same is done in the traditional 
way, through clinical examinations and additional tests, you need to seek 
alternatives to a diagnosis early and effective. Within these options are biomarkers, 
which are molecules present in blood and other fluids, represent a specific disease 
so the diagnosis and early prognosis may be of great help   and thus it allows improve 
the quality of life of patients. The importance of biomarkers in the early diagnosis of 
FIP, as well as  demonstrating that its use may also help in diseases such as acute 
renal insufficiency and hypertrophic cardiomyopathy, the idea is to provides  well-
being  to the pet because the early diagnosis allows the realization of  treatment 
soon and in the same way an early management of the disease, the idea is to  
Provides information to the professionals collected and updated, information that 
allows them to make decisions regarding the diagnosis and prognosis of the 
diseases, in this way to inform in a timely manner the owners of affected pets. Since 
animal welfare is the most important for veterinarians and owners, provides 
knowledge about the use of biomarkers that allow the diagnosis and early prognosis 
of different diseases,the knowledge about the use of biomarkers in the diagnosis 
and prognosis of these diseases allows the work of veterinarians to be a little easier 
and thus improves the quality of life of patients who require the use of them. Some 
biomarkers that are useful in humans have not been counted useful in felines, 
however, recent studies have shown that there are some quite promising new 
candidates. 
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Framework 
 
¿which is a biomarker? 
 
A biomarker is a physiological, biochemical or morphological characteristic that is 
measurable and evaluable at the molecular, biochemical or cellular level that acts 
as an indicator of a normal or pathological biological process, or as a response to a 
therapeutic intervention. The Biomarkers are increasingly being investigated in the 
treatment of different disease. There has been a growing focus on the use of 
biomarkers as an alternative or adjunct to invasive procedures.  
 
A biomarker is a substance that is: 
 Specific for the organ or tissue under study 
 Released in proportion to an injury or illness 
 
What biomarkers are for? 
 
Biomarkers are used to confirm exposure to a harmful agent, and they also allow 
provide a system to monitor the individual susceptibility to a toxic, also to 
quantitatively assess the harmful effects that a toxic agent may be generating within 
the body of the affected individual or organism. 
The biological markers are also they use to recognize, characterize and monitor the 
state, and also to follow up on a disease(1). 
 
What is the discovery of a biomarker? 
 
The discovery of biomarkers is a complex and challenging process. The main rating 
corresponds to mass spectrometry (MS) technology combined with the associated 
disease differential(2). An analysis should be performed, a widely used approach to 
statistically significant differences in protein expression or production of metabolites 
between disease and control. Cohorts identify potential biomarkers(2).  
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Biomarker Discovery workflow(2):  
 
 
 
Are biomarkers specific for diseases? 
Biomarkers are not always specific for the organ of interest because some proteins 
that act as biomarkers are secreted by various tissues(2). 
 
For example clusterin messenger RNA is found, which is ubiquitous in all tissues of 
animals and is abundant in the liver, stomach, brain and testicles. Similarly, NGAL 
is expressed and secreted by immune cells, hepatocytes, adipocytes, epithelial cells, 
liver, lung, colon and renal tubular cells in various pathological states, as well there 
is alkaline phosphatase that serves as an example and is secreted by multiple 
tissues, and is used to evaluate liver function, however, current diagnostic methods 
measure Levels of alkaline phosphatase, both hepatic and bone(2). 
 
the use of this marker to control bone metabolism or liver dysfunction can be 
compromised if an immunosorbent assay linked to a simple enzyme is performed 
The approach (ELISA) that measures all the isoforms is adopted. 
Therefore, it is important to measure the proteins specifically of the target organ or 
disorder to avoid false diagnoses. This specificity could be achieved through 
orientation subtle differences, such as post-translational modifications (PTM) that 
are specific to the disease process to develop accurate diagnoses(2). 
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Which is the biomarker of preference? 
 
The serum is preferred because it is considered the most complete circulating 
representative the bodily processes and the physiological and pathological 
processes(2). 
 
What are the parameters that biomarkers detect? 
 
  Heart disease in early stages (asymptomatic patients)  
  differentiate if dyspnea has a cardiac or respiratory origin  
  And finally follow up on medical treatment and as a guide for early and 
timely diagnosis. 
 
There are different types of biomarkers that allow measurements of the stages of 
different diseases in cats, therefore they are the ones that are responsible for 
showing in which state the patient is in, in the same way it allows everything to be 
perform more safely and quickly to achieve a quick recovery. 
 
¿How a biomarker is defined? 
 
A biomarker is defined as a physical, functional or biochemical indicator of a 
physiological or disease process that has a diagnostic and / or prognostic utility with 
the ability to be measured accurately and reproducibly(2). 
 
The current role of biomarkers is rapidly going into 
Expansion beyond the diagnosis of progression and regression of diseases(2). 
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Why are biomarkers becoming essential? 
 
They are becoming indispensable since they allow to accelerate the discovery and 
development of drugs, they allow to understand the effectiveness and the toxicity of 
the therapies and to determine the duration of the therapies(2). 
 
What is the role of a biomarker? 
  
Meet the ability to measure accurately and reproducibly, the current role of 
biomarkers is to allow rapid expansion beyond the diagnosis of progression and 
regression of diseases(2). 
 
 
How is the journey of a biomarker? 
From the bank to the clinic is long and difficult, there is a variety of biomarkers 
discovered and reported regularly, but some of them reach the clinics. There are 
several requirements and strict criteria that a the biomarker must comply to be an 
ideal marker and be adopted in clinical practice(2). 
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Journey of  biomarkers from research laboratory to clinic(2).  
 
 
 
 
CRITERIA FOR DETECTING A GOOD BIOMARKER IN A CLINICAL 
PRACTICE(3) 
 
 Should provide information that is not available through a clinical evaluation 
 allow the average level at which it should assist doctors in decision making 
 the measurements on the disease level must be precise and repeated must 
be offered at a reasonable cost and with short response times 
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THE FOLLOWING CAN BE USED AS BIOMARKERS 
 
The blood-based biomarkers can able to report that so advanced or the state of the   
disease are a subject of considerable interest. A biomarker is a substance that have 
many features :(4) 
Cardiac biomarkers allow veterinary physicians to assess the presence of cardiac 
conditions in both dogs and cats, through quantitative assessment using the 
following analytical parameters: 
 
 Myocardial function  
 Myocardial injury (with loss of the integrity of cardiac myocytes) 
 
Another biomarker can be the thymidine kinase (TK) is a cytoplasmic enzyme 
involved in the phosphorylation of deoxythymidine in deoxythymidine 
monophosphate as part of the important one-step recovery pathway of pyrimidine 
synthesis. TK exists in both cytosolic (TK1) and mitochondrial (TK2) forms, TK1 is 
closely associated with cell proliferation, and its activity markedly increases after the 
G1-S transition in the cell cycle and then decreases. The experience of 
measurement of sTK activity in cats is limited to a small pilot study that indicated the 
potential of this marker in feline lymphoma and justified further study, the clinical 
response to treatment, feline leukemia virus status (FELV), location and clinical 
stage remain the only factors that remain the only predictions so far consistent in 
cats, this due to the scarcity of information on the 
prognosis, a marker that can help the diagnosis and prognosis of this disease may 
be thymidine kinase(5). 
 
 
 
 
 
 
10 
 
What are the properties of an ideal biomarker? 
 
From a physiological point of view, an ideal biomarker produces a constant rate and 
maintains a constant plasma concentration; it is characterized by low intraindividual 
variation, and there is no plasma protein binding, tubular secretion, tubular 
reabsorption without catabolism or extrarenal authorization (Ghys et al., 2014a). 
 
Medically, an ideal biomarker for CKD must be strongly correlated with GFR, more 
sensitive and specific than creatinine, and is not affected by comorbidities, age, sex 
or race If the biomarker is correlated with a specific pathological process such as the 
child (damage or renal tubular fibrosis or phosphorus metabolism), this would shed 
additional light on the pathophysiology of the disease as it progresses. In addition, 
the ideal biomarker should be shown to alter this in response to the therapy 
performed. 
 
Characteristics of an ideal biomarker(2). 
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 Natriuretic peptides: they are released when there is cellular stress, which is 
why they are indicators of cardiac functionality. Its action would be to promote 
natriuresis and vasodilation, they have an inhibitory action of renin, are 
antiarrhythmogenic and have lusitropic effects (relaxation) in the heart (6). 
 
 
 Atrial natriuretic peptide: (ANP) it is secreted in the atrial tissue in response 
to the atrial stretch that occurs when cardiac dysfunction is generated, by 
increasing the left atrial pressure and when a heart failure situation is going 
to occur(2). 
 
 Natriuretic type B peptide: (BNP) It is synthesized mainly in the ventricle when 
there is heart disease, due to an increase in ventricular stress (volume or 
pressure overload, ventricular hypertrophy). It is the one that is being used 
more on a practical level. For identification, a fragment (aminotermin form) of 
its pro-hormone (proBNP) is used, which is called NT-proBNP (with greater 
size, stability and half-life than BNP, making it easier to measure) (6). 
 
CARDIAC TROPONINS: are specific indicators of myocardial cell damage, since 
they are released when cardiac, acute or chronic injuries occur. Blood levels will be 
proportional to the severity of the existing myocardial injury. There are three protein 
subunits of the Troponin complex found in skeletal and cardiac muscle:  
 
 TnI- TnT- TnC  Its function in the cell corresponds to the coordination of the 
excitation contraction of sarcoplasmic proteins. Cardiac troponin I (cTnI) is 
the most specific for the cardiac muscle(7). 
 
ENDOTHELINES: as the main effect vasoconstriction, corresponds to fibrogenic and 
are responsible for promoting contractility. They are a powerful stimulus for the 
Renin-Angiotensia-Aldosterone system, and also for the sympathetic nervous 
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system. Its plasmatic levels increase significantly in congestive heart failure (with 
good correlation to the functional type of CHF) and with pulmonary circulatory 
alterations, which is why it can be very useful for the assessment of pulmonary 
hypertension and pulmonary vessel anomalies(6). For over a decade have been 
using the biomarkers for the diagnosis of heart disease in cats, and this has created 
intrigue in veterinary medicine professionals, willing to implement the use of 
biomarkers for the diagnosis of other diseases such as hypertrophic cardiomyopathy 
and liver lipidosis. The role of cardiac biomarkers in clinical decision-making(5). 
Although echocardiography is useful for identifying cats with cardiogenic respiratory 
distress, it may not always be available. Measurement of a cardiac biomarker may 
be helpful if a blood sample can be obtained with minimal restraint, and this might 
be safer than thoracic radiography. Eight studies were identified that compared 
cardiac biomarker concentrations in cats with cardiac and non-cardiac causes of 
respiratory distress: four studies investigated cTnI1e4 and four investigated 
natriuretic peptides (of which, all four featured NTproBNP and one also featured 
NTproANP). Only a cutoff value to identify cardiogenic dyspnea in cats is unlikely to 
be clinically useful(5), the hepatopathy induced by metabolic changes that lead to 
an excessive accumulation of triglycerides in the liver tissue, with resulting 
cholestasis and hepatic dysfunction(7). The general disease signs in cats are various 
but consistent with hepatic failure, enlargement, or insufficiency. The course of the 
disease is generally chronic, but clinical illness may appear acute. Concurrent 
conditions associated with poor nutrition may also be present. The laying hen may 
die acutely of fatty liver hemorrhagic syndrome resulting from rupture of hepatic 
blood vessels during egg lying. It should be stressed that other forms of lipid 
deposition (e.g., atherosclerosis; fat deposition in kidneys, skin, abdomen, lungs, 
and spleen) that lead to other physical findings can be found concurrently with 
hepatic lipidosis(7).  
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IN DISEASES THAT ALLOW TO BE DIAGNOSED AND TREATED WITH 
BIOMARKERS ARE FOUND 
 
Feline hypertrophic cardiomyopathy 
 
This disease is characterized by diastolic dysfunction that occurs as a consequence 
of thickening of the myocardium of a non-dilated left ventricle due to disorders related 
to the cardiac muscle itself, instead of secondary processes that present with 
ventricular hypertrophy such as aortic stenosis. hyperthyroidism, acromegaly or 
other diseases of non-cardiac origin (Kittleson, 2005). Males are more predisposed 
than females and the condition is more frequent in young cats (from 5 months to 6 
years of age). 
 
CMH can be mild, moderate or severe. The severe form increases the stiffness of 
the left ventricle by itself. In addition, the blood flow that supplies a very thickened 
myocardium can be compromised, inducing ischemia, cell death and fibrosis. In turn, 
the formation of fibrous tissue in the heart muscle further intensifies the rigidity of the 
chamber and is probably the main cause of the marked diastolic dysfunction seen in 
this disease (Kittleson, 2005). 
 
 
Feline hepatic lipidosis 
 
Feline hepatic lipidosis (FHL), the most common hepatobiliary disease in cats, is 
characterized by the accumulation of excessive triglycerides (TGs) in more than 80% 
of the hepatocytes, resulting in a greater than 50% increase in liver weight, 
secondary impairment of liver function, and intrahepatic cholestasis(7). 
This  disease  have A specific geographic distribution  has been suggested based 
on the available reports of FHL from different areas, including North America, Great 
Britain, Japan, and Western Europe. The higher prevalence of FHL in these areas 
might be secondary to feeding habits of cat owners and a high incidence of obesity 
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in the feline population, the main metabolic abnormalities that lead The accumulation 
of TG in hepatocytes is not yet completely known, but could consist of alterations in 
the pathways of uptake, synthesis, degradation and fatty acid secretion (FA)(7). 
 
Chronic kidney disease:  
 
Chronic kidney disease commonly affects dogs and cats and generally with poor or 
erroneous results during its advanced stages, the general prevalence of the disease 
in dogs is 5 to 7% and in cats it ranges from 6 to 20%, but the prevalence is 
increasing according to the age of the pets, that is, in dogs it has an increase of 15% 
when they are older than ten years, and in felines it has an increase of 31% when 
they are over fifteen years of age(8). The chronic kidney disease (CKD) is a 
progressive disease in elderly cats; it has no known etiology and there is no specific 
cure other than renal transplantation, this disease is characterized by its continuous 
advance, which generates the irreversible loss of renal function, which is caused by 
the loss of renal architecture. And the individual nephrons characterized by 
progressive scars that ultimately result in structural damage to the kidney, CKD is a 
silent disease that can remain asymptomatic until an advanced stage, cats become 
more vulnerable to acute kidney injury (ARF) after being exposed to risk factors such 
as nephrotoxic drugs or major surgeries. AKI is characterized by an abrupt 
deterioration of renal function and important causes include nephrotoxic medications 
such as non-steroidal anti-inflammatory drugs (NSAIDs) and chemotherapy, 
infections, vasculitis, surgery, neoplasia and obstruction of the urinary tract by kidney 
stones. acute renal injury (AKI) has a poor prognosis and is associated with mortality 
rates that range between 50% and 60% in companion animals (8).  After AKI, renal 
function could recover completely in surviving patients; there could be an incomplete 
recovery that results in CKD; I could have exacerbation of the pre-existing CKD, 
accelerating its progression; or there may also be no full recovery that requires 
permanent kidney replacement therapy. 
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Biomarkers allow developing an attempt to improve diagnostic capacity, which 
allows precision for the detection of acute and chronic kidney diseases including the 
potential for early detection of the disease(8). 
 
¿why the use of biomarkers should be promoted? 
 
Because biomarkers allow to identify the different processes that cause various 
diseases such as kidney disease, glomerular damage, tubular stress or 
dysfunction(8). 
 
What are the characteristics of a specific biomarker for kidney disease(8)? 
 
 Able to detect AKI and CKD 
 Sensible to detect the disease early 
 Able to document the disease, and allow monitoring of disease progression 
 Predictive of clinical outcome 
 Should not be invasive 
 Must be low cost 
 Must be available in a laboratory or reference point 
 
Feline infectious peritonitis: 
feline infectious peritonitis (FIP), is a viral disease resulting from feline coronavirus 
(FCoV) in which inflammation plays an important role in FIP infection, since the 
inflammatory response occurs during the course of FIP that participates in 
pathogenesis, producing fibrinous serositis, with accumulations of highly proteinic 
fluid within the body cavities, disseminated pyogranulomatous formation, 
hypergammaglobulinemia, and the development of immune complexes. Increases 
in acute phase proteins (APP), which are markers of inflammation, such as alpha-1 
The serum glycoprotein or amyloid A can be used as a diagnostic aid in this disease. 
Knowing the relationship between inflammation and oxidation stress, it could be 
postulated that oxidative stress may be present in cats affected by FIP(4) 
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(8). 
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What is the creatinine? 
Creatinine is a by-product of endogenous muscle metabolism, creatinine is 
distributed in the body water, is almost entirely freely filtered at the glomerulus, is not 
absorbed by the renal tubules and undergoes minimal tubular secretion. As such, it 
inversely correlates(8). 
 
 
What are the limitations of creatinine? 
 
 Creatinine measurement is insensitive for early stage renal failure(8). 
 
 The relationship between glomerular filtration rate and serum creatinine is 
nonlinear when kidney disease is early(8). 
 
 factors such as age, sex, bodyweight and breed can all affect measured GFR 
values(8). 
 
 
 
What is cysteine C? 
 
Cystatin C is a cysteine proteinase inhibitor produced constitutively by all nucleated 
cells, which is filtered freely in the glomerulus and is absorbed and catabolized in 
the cells of the proximal tubule, with minimal tubular secretion(8). 
 
Which are the biomarkers for the tubular dysfunction? 
 Low molecular weight proteins: Retinol-binding protein(8). 
 Low molecular weight proteins (LMW): `1 and a2-microglobulins(8). 
 Enzymuria: N-acetyl-a-D-glucosaminidase and f-glutamyl transpeptidase(8). 
 Neutrophil gelatinase-associated lipocalin(8). 
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Retinol-binding protein in cats 
 
Retinol-binding protein (RBP) is a 21-kDa low molecular weight protein (LMW) 
protein synthesised in the liver. Unbound RBP is filtered at the glomerulus and is 
almost completely reabsorbed and catabolised in the proximal tubular cells(8).  
 
Assessment of tubular function using RBP in hyperthyroid cats is problematic 
secondary to large inter-individual variation, and may indicate that this is not a 
suitable marker of feline renal tubular injury(8) 
 
 
Enzymuria: N-acetyl-a-D-glucosaminidase and f-glutamyl transpeptidase 
N-acetyl-β-D-glucosaminidase (NAG) and γ-glutamyl transpeptidase (GGT) 
 
 Are proximal tubular enzymes involved in protein processing. 
Studies have shown poor correlation between creatinine concentration and the NAG 
index in healthy cats and cats with urinary tract disease, and NAG index was not 
predictive of development of azotemia in geriatric cats or those with treated 
hyperthyroidism. Therefore, it is suggested that NAG is not a good biomarker for 
CKD in cats(8). But NAG and GGT may be well suited for detection of early tubular 
injury. In ongoing kidney injury, depletion of tubules decreases enzyme excretion(8). 
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Nexus between CKD and acute kidney injury(2). 
 
 
 
 
CREATININE AS A BIOMARKER OF KIDNEY FUNCTIONS AND FALSE 
ANSWERS(2). 
 
 Serum creatinine has been characterized as the standard care test for renal 
function and disease for about 100 years. 
 
 Ceric creatinine is a product of muscle metabolism degradation and correlates 
with muscle mass. As a result, renal function is overestimated in cachectic. 
 
 Animals of low musculature, can give rise to false diagnoses of renal 
dysfunction. 
 
 In heavily muscled animals, the metabolism of creatinine must reach and 
remain stable. 
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Arginine as a biomarker 
 
Arginine is a conditional essential amino acid and most animals produce theirs. 
 
The post-translational transformation of the arginine protein groups occurs in the 
mitochondria. The methylation of arginine occurs mainly in histones for the purpose 
of transcriptional regulation. In general, the asymmetric methylation of arginine. 
(ADMA) activates transcription, while symmetric methylation (SDMA) is a repressive 
signal. The proteolysis of these methylated proteins results in the release of SDMA 
and ADMA in the cytoplasm and then from the cell to the circulation through cationic 
transporters, although ADMA has been shown to be an endogenous inhibitor of nitric 
oxide synthase (NOS) and a marker for cardiovascular disease, SDMA does not 
interfere with NOS36 activity or arginine transport at physiological concentrations. 
Approximately 80% of circulating ADMA is eliminated through enzymatic pathways, 
which makes it a poor marker for kidney function. However, SDMA is strictly 
eliminated through the kidneys by filtration and renal excretion, therefore circulating 
concentrations are affected mainly by changes in GFR and correlate with renal 
function(2). 
 
THE GLOMERULAR FILTRATION RATE AND CORRELATION 
 
GFR is the gold standard for determining renal function in people and animals. 
However, the GFR can not be measured directly, this is measured through the 
urinary or plasma clearance of several small molecules, including inulin and 
iohexol(2). 
 
The first evidence of the use of SDMA to assess kidney disease in dogs that use a 
remnant the kidney model was published in 2007 and resulted in strong correlation 
of SDMA with mGFR by inulin elimination, but the most recent study showed a linear 
relationship between GFR levels and SDMA in a population of cats and female 
carriers, affected and males from a colony of dogs with hereditary nephropathy 
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linked to X54 compared to mGFR using iohexol clearance. In another study on CKD, 
SDMA concentrations showed an increase and correlated with serum creatinine. the 
evaluation of hyperthyroid cats showed that the level of SDMA correlated better than 
serum the creatinine level with mGFR estimated by elimination of iohexol before 
starting the diet therapy and at 6 months of follow-up(2). 
 
Feline infectious peritonitis (FIP) 
 
The diagnosis of feline infectious peritonitis is usually made when the disease is at 
a very advanced stage, making it more difficult to diagnose and convert the 
treatment. As we know, this is a virus, for example, feline infectious peritonitis can 
be detected early, this is a virus. What can be done quickly with leukocytes, 
macrophages and monocytes? The production of plasma levels of VEGF, was also 
more important in cats by PIF (feline infectious peritonitis), this virus is an RNA 
virus(9), this virus can be attacked in several ways, such as wet or dry and more 
aggressive It is the dry form(9). It has also been shown that the virus has several 
factors that can act as inhibitors in the first phase or in vitro(9), but that they do not 
have the capacity to behave as such. The virus can kill cats in just a few days and 
is highly lethal because medical treatment is too strong, it is like treating cancer in 
humans, medicines that are used for the body, decreasing the resistance of the body 
and there when bacteria Opportunists enter the body to attack in different ways. This 
virus has been validated with the theory of mutation in several studies that have 
resulted in the FIP gaining tropism due to the alteration of macrophages, which 
causes the virus to deviate from the service and become a systemic pathogen of the 
virus of macrophages(9). This virus does not have an effective vaccine at this time, 
it is available only to prevent, but this is not enough, it must be a vaccine that does 
not allow the virus to enter the body. We have found 16 compounds that function as 
antiviral compounds against a local strain of FIP(9). 
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The state of the health of cats is related and associated with the functions of the 
proteins of the acute phase. These results were obtained using multivariate 
regression models(6). 
 
Still no studies have been conducted in which there is shown that the presence of 
oxidative stress during FIP , but this is present in various diseases in this species, 
such as, diabetes mellitus, feline immunodeficiency virus (FIV) infection, chronic 
renal failure  The inflammation plays an important role during the infection FIP as a 
major inflammatory response occur during the course of FIP, which is involved in the 
pathogenesis producing fibrous serositis with accumulations of high protein fluid into 
body cavities(4). During the acute phase proteins increased (APPs), which are 
markers of inflammation such as alpha - 1 glycoprotein or serum amyloid A can be 
used as an aid in the diagnosis of FIP. A way of knowing if there is the presence of 
oxidative stress in FIP, is given from knowledge of the relationship between 
inflammation and oxidative stress(4). Also this corona-virus is associated with mild 
or subclinical enteric infections, only between 5% and 12 % of cats test positive 
develop FIP(10). Among serotypes they have been identified the type I and type II 
that everyone has the capacity to develop FIP. Corona-viruses have been 
discovered in a variety of species such as; birds, humans, farm animals and other 
mammals(10). 
 
A reverse transcriptase polymerase chain reaction (RT-PCR) for the detection of 
feline corona virus (FCoV) messenger RNA in peripheral blood mononuclear cells 
(PBMCs) is described(11) The corona viruses are abundant in populations of cats 
with particularly high prevalence in farms and households with multiple cats, the virus 
reproduces sporadically (not cause epidemics) disease is mostly fatal, its biology is 
still little known, its prevention is difficult, occurs worldwide and affects domestic and 
wild cats(11), persistently infected cats may harbor in their intestines, blood FCoV 
or tonsils, and remove the virus in feces or spittle, these cats can act as a continuous 
source of infection, be able to detect these cats it is essential; not only for our 
understanding of their role in the spread of corona virus infection, but also in 
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determining what is the chronic potential role in the induction of clinical FIP(12). Now 
known to FCoV can be detected using RT-PCR techniques, blood up to 95 % of 
healthy cats FCoV endemic households(12). 
 
The infection with feline infectious peritonitis as a result of clinical signs is an 
invariably fatal virus despite clinical intervention. As FIP is an immune disease, 
treatment is directed primarily to control the immune response triggered by infection 
with feline corona virus (FCoV)(13).The infection is controlled by 
immunosuppressants such as prednisolone or cyclophosphamide which can slow 
the progression of the disease but can’t produce the cure is known that in almost 
every case reports of attempted therapy for FIP clinic, glucocorticoids have been 
used(13). 
 
Many studies evaluated the effect of glucocorticoid therapy for uncontrolled FIP(13). 
the chronic renal disease is more frequent in geriatric cats reaches a prevalence 
from 30% to 60%, frequently present in cats older than 10 years, taking into account 
that chronic renal cat disease is irreversible and progressive, for this reason it 
becomes necessary that this disease is detected and prevented in time since this 
allows the improvement of the quality of life of the cat as well as allows it to live for 
a longer time. The glomerular filtration rate is considered gold and is the standard 
method for the evaluation of renal function, but it is not used frequently since it 
spends too much time, but there are indirect GFR markers such as serum creatinine 
and urea which are frequently measured and allow to estimate GFR, these markers 
are insensitive, the urinary cystatin is a biomarker for tubular damage in humans and 
canines, a study made it possible to find that cystatin is a promising biomarker for 
estimating TGF in feline medicine(14). 
 
an imbalance between oxidative and antioxidant system or oxidative stress, as well 
as the accumulation of reactive oxygen in the organism, produce a detrimental effect 
on the functional and structural integrity of biological tissues, in this way then cats 
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are more susceptible to stress and damage oxidative, with great influence by the 
form of the spleen of this species(4). 
 
The relationship between stress and oxidative damage has been demonstrated in 
diseases such as diabetes mellitus, chronic renal failure and feline 
immunodeficiency virus. Studies on the influence of oxidative stress on feline 
infectious peritonitis are not yet known(4). FIP disease in some populations can 
attack between 50% and 80% of pure-bred cats and in creole cats reaches a 15% 
affectation. This disease also has different forms of presentation, by effusion rich in 
proteins within the body cavities(11).  
 
And the dry PIF that has characteristics like:(11) 
 
• The presence of piogranulomas in different organs. 
 
• At the cutaneous level, PIF produces granulomatous nodules and ulcers 
present by vasculitis around the head and neck. 
 
The most frequent clinical signs in cats with any FIP variance are:(11) 
• Fever 
• increase in weight loss 
• lethargy 
 
 
The type of FIP that is present depends on the cat's immune system, and other 
clinical signs also depend on the affected organ, the serological test, with a high titre 
of antibodies can reveals FcoV infection, but it is impossible determine whether the 
cat will develop PIF, to detect the presence of this disease, some combinations have 
been made as is the concentration of SAA with a high title of antibodies against the 
coronavirus to diagnose the presence of FIP. This study yielded significant results 
that allowed the conclusion to be obtained by comparing levels of SAA of cats with 
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FIP and of healthy cats with a high titer of antibodies. The SAA concentration was 
increased 10-fold in cats with FIP, compared to healthy cats exposed to FCoV(11). 
As it is already known during FIP disease inflammation occupies a very important 
place because in its different phases attacks in various ways, within its pathogenesis 
is the production of fibrinous serositas, which has accumulations of liquid with high 
protein content inside the cavities as well as the formation of disseminated 
piogranulomatous, hypergammaglobulinemia, and the development of immune 
complexes. During the acute phase of this disease increases of the proteins (APP), 
which are markers of the inflammation such as:(4) 
 
• alpha-a  
• the glycoprotein or amyloid A contained in the serum 
 
 
Which are used and are help to diagnose, it could be said that oxidative stress is 
present in cats with FIP(4). Quantitative analysis of acute phase proteins, especially 
type A serum amyloid (SAA) and the alpha-1 acid glycoprotein (AGP) provides 
excellent guidance for diagnosis, prognosis, and monitoring as well as the prognosis 
of many other diseases and conditions affecting the world's feline population, the 
acute phase protein (AGP) plays an important role during the diagnosis of FIP, it can 
also be used in studies of pathogenesis of this disease. The quantification of feline 
PGA in the diagnosis of FIP has allowed an improvement in the specificity and 
clinical sensitivity of this disease. Since the forecast of cats with this infection is very 
poor(11). It is important to differentiate it from conditions with signs such as 
myopathies. Plasma AGP values or feline exudate infected with FIP reach levels 
greater than 1.5 g / L. The Hp concentration is higher in cats with FIP than in healthy 
cats, but this protein has no any value in the diagnosis of FIP. The total concentration 
of acid serum can allow the support of a diagnosis of FIP with extremely high serum 
concentrations (greater than 800 mg / L), suggesting that the saturation of AGP with 
sialic acid (hypersialization) may be involved with interactions between this virus and 
its host(11). 
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The results were the following: 
 
 The concentration of amyloid A serum log -transformed was higher in older 
cats, in sick cats and in females. 
 The concentrations of logarithmically transformed α1 glycoprotein acid and 
haptoglobin were higher in old cats and were associated with interactions of 
health status (sick / healthy) and sex (male / female). 
 
How to determine protein concentrations in the acute phase feline(7). 
 
 Amyloid serum A 
The concentration of serum amyloid A was determined using a solid phase sandwich 
Elisa kit. 
 Alpha 1-acid glycoprotein 
A radial immunodiffusion kit (Tridelta Development Limited) was used to measure 
acid-1 glycoprotein. 
 Haptoglobin 
Haptoglobin was measured using a kit (Tridelta Development). This kit is based on 
the detection of a color change as a result of the interactions between haptoglobin, 
hemoglobin, a chromogen and hydrogen peroxide. 
 
 Albumin 
Serum albumin concentrations were determined at the University at the Veterinary 
Clinical Pathology Laboratory of Queensland using an Olympus analyzer using a 
photometric color test for the quantitative determination of albumin concentration. 
 
Measurements of acute phase protein concentrations work as biomarkers and allow 
veterinarians to have a more detailed and real result of the disease phase of the 
patient, as well as provide a diagnosis, prognosis and timely treatment to the 
patients. Cats affected by the various diseases to which they are exposed every day. 
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Feline acute pancreatitis 
 
Feline acute pancreatitis is the most common disorder this disease characterized by 
acute inflammation of the exocrine pancreas, and which results in clinic-pathological 
findings compatible with extra-hepatic cholestasis, the incidence of acute 
pancreatitis, the causes are unknown, this disease has association occasionally with 
pancreatic neoplasia and fortuitous infestation. Because hepatic lipidosis and acute 
pancreatitis can have very similar clinical presentations in felines. but necropsy 
studies suggest that it is not uncommon. A small number of cases in which this 
disease has been related to trauma, infection with feline infectious peritonitis virus 
or Toxoplasma gondii, or inflammation of the biliary tract have been presented(15). 
 
Feline pancreatic disease can be detected under direct and indirect serum markers 
of hepatic fibrosis, such as hyaluronic acid; new markers of hepatocellular injury, 
such as circulating microRNAs; and quantitative tests of hepatic microsomal 
function(16). 
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General Aim  
 
Collect information about the different biomarkers used for the diagnosis, prognosis 
and treatment in the various diseases in cats such as feline hypertrophic 
cardiomyopathy, feline hepatic lipidosis, feline immunodeficiency virus, chronic renal 
failure and feline infectious peritonitis. Information on biomarkers for the analysis of 
feline viruses and their ability to perform an examination that allows to have more 
detailed information about these diseases, although most of these are fatal, may 
contain some factors that act as inhibitors, some of them they are: chloroquine, 
mefloquine, amiloride and hexamethylene which are present during the initial stage 
of the virus, the infection can also change the stages of the vascular endothelial 
increase factor (VEGF) making these changes to extend the amount of plasma, 
since which is related to the abundance of the disease, the vascular components of 
the absorption as amounts of the spills and the cats with increased FIP. 
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Materials and methods 
 
Perform a search of information in the different databases, such as Science direct, 
scopus, pub med, clinical key, web of science, articles in English and Spanish of the 
last ten years. 
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